Grants and Contracts Details
Description
The National Lung Screening Trial (NLST) revealed a reduction in lung cancer mortality that has
led to draft recommendations by the US Preventive Services Task Force (USPSTF) in favor of
LDCT-based lung cancer in selected high-risk groups. Provider organizations also recommend
that high-risk individuals be engaged in a process of shared decision making (SDM) about LCS.
The goal of SDM is to ensure patients understand potential benefits, harms, and uncertainties
related to screening, and make screening decisions based on evidence and their personal
values and preferences. Our preliminary data shows that there is a substantial need to raise
awareness of LCS among primary care providers (PCPs) and screening-eligible individuals.
PCPs are the most influential source of cancer screening recommendations, and they are likely
to play a pivotal role in disseminating LCS. However, our evidence shows that PCPs do not
have adequate knowledge of the potential benefits and harms of LCS and they struggle to
implement SDM with regard to cancer screening, undermining optimal LCS implementation.
Given limited knowledge of LCS among PCPs and known barriers to achieving SDM in clinical
practice, there is a need for provider-targeted interventions to promote LCS knowledge and
facilitate SDM regarding LCS. This project will develop and evaluate a web-based and broadly
disseminable intervention designed to promote SDM about LCS. The intervention builds on pilot
data from our recently developed continuing education program targeting PCPs. Web-based
continuing education programs can both communicate accurate information about LCS to PCPs
and train them effectively in the skills needed to facilitate SDM with patients considering LCS. In
Phase I, this project will develop and test the usability of a web-based continuing education
program (LCS-CE) designed to inform PCPs about the evidence supporting LCS, new LCS
guidelines, and implementation of SDM regarding LCS, incorporating engaging text, audio, and
video vignettes examples. In Phase II, investigators will conduct a two group parallel
randomized trial comparing the impact of LCS-CE against a web-based delivery of the USPSTF
LCS guidelines for PCPs. We hypothesize that the LCS-CE program will lead to greater
knowledge of LCS, superior self-efficacy in SDM skills, more favorable attitudes toward SDM for
LCS, and greater implementation of SDM for LCS. This T3 translational study has the potential
to facilitate implementation of LCS and fulfill the promise of reduced lung cancer mortality in
Kentucky and nationally.
Status | Finished |
---|---|
Effective start/end date | 4/1/16 → 3/31/20 |
Funding
- KY Lung Cancer Research Fund: $150,000.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.